MedTrace Logo

Singapore Atrial Fibrillation Study

NCT02791022 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2016-06-06

No results posted yet for this study

Summary

Atrial fibrillation is a common disease in the aging population that has severe implication if left untreated as it leads to embolic stroke and other embolic phenomenon. Embolic stroke in particular has severe implications to our community as the cost of care for such immobile patients can be extremely high. Atrial fibrillation typically begins as Paroxysmal atrial fibrillation (PAF), which makes early detection extremely difficult as the PAF may only occur transiently in the initial stages. Long term continuous ECG monitoring is currently required over weeks to detect early PAF. Current devices typically need to be implanted (loop recorders) to be sensitive enough to detect infrequent episodes of PAF. New generation ECG remote devices (non-invasive) are however now available that are wearable over long periods and can send data directly to a database for centralized collection and analysis of the data. The aim of this study will be to use such a device to evaluate the incidence of PAF in different population of patients, with each patient wearing and sending continuous ECG data for periods of a week or more to a central database, across several public hospitals in Singapore.

Conditions

Interventions

DEVICE

SPYDER ECG sensor

Sponsors & Collaborators

  • Changi General Hospital

    collaborator OTHER

  • Singapore General Hospital

    collaborator OTHER

  • National University Hospital, Singapore

    collaborator OTHER

  • National Heart Centre Singapore

    lead OTHER

Principal Investigators

  • Chi Keong Ching · Singhealth Foundation

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02791022 on ClinicalTrials.gov